赤身の牛肉の摂取が心臓代謝の健康と腸内微生物叢に及ぼす影響
This study is investigating the benefits of lean beef consumption on cardiometabolic health and gut microbiome.
調査の概要
状態
条件
詳細な説明
The study is a 6-wk randomized, controlled, and parallel arm clinical trial. Participants will be randomized to consume either lean grain-fed beef, lean grass-fed beef, or plant-based meat for 6 weeks. Outcomes assessed will include metabolic, inflammatory, and gut microbiome markers.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Jaapna Dhillon
- 電話番号:573-884-2103
- メール:jdhillon@missouri.edu
研究場所
-
-
Missouri
-
Columbia、Missouri、アメリカ、65211
- 募集
- University of Missouri-Columbia
-
主任研究者:
- Jaapna Dhillon, PhD
-
コンタクト:
- Jaapna Dhillon
- 電話番号:573-884-2103
- メール:jdhillon@missouri.edu
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Age: 18-45 years of age
- BMI: 18-35 kg/m2
- Willingness to consume study foods.
- Willing to comply with study protocol.
- Consistent diet and activity patterns for 4 weeks
- Weight stable (≤5 kg change over the last 3 months)
- Non-smoker >1 year or more
Exclusion Criteria:
- Allergies to foods provided in the study
- Diabetes
- Gastrointestinal disease and/or bariatric surgery
- Uncontrolled hypertension and blood pressure ≥ 180/110
- Illicit drug use
- Recent consumption of antibiotics or probiotics
- Recent start of medications that affect metabolism or appetite.
- Recent blood donation
- Drug therapy for coronary artery disease, peripheral artery disease, congestive - heart failure, or dyslipidemia
- Pregnant or lactating individuals
- Taste or smell disorders
- High consumers of red meat or plant-based meat (≥ 4 times/week)
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Lean (≥90%) Grass-Fed Beef
The quantity of beef will be adjusted or normalized based on their individual energy requirements. The specified amount will be 4 oz. per day or 28 ounces per week for participants with an energy requirement of 2000 kcal. Participants will consume meals for six weeks. |
The specified amount will be 4 oz. per day or 28 ounces per week for participants with an energy requirement of 2000 kcal. |
|
実験的:Lean (≥90%) Grain-Fed Beef
The quantity of beef will be adjusted or normalized based on their individual energy requirements. The specified amount will be 4 oz. per day or 28 ounces per week for participants with an energy requirement of 2000 kcal. Participants will consume meals for six weeks. |
The specified amount will be 4 oz. per day or 28 ounces per week for participants with an energy requirement of 2000 kcal. |
|
アクティブコンパレータ:Plant-Based Meat
Plant-based meat (beyond meat product) would be macronutrient matched to the same quantities of meat prescribed for a given energy level. Participants will consume meals for six weeks. |
Plant-based meat would be macronutrient matched to the same quantities of meat prescribed for a given energy level. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
LDL-C concentrations
時間枠:Baseline, week 6
|
Lipid profile |
Baseline, week 6
|
|
Interleukin-6 concentrations
時間枠:Baseline, week 6
|
Inflammatory marker |
Baseline, week 6
|
|
Gut microbial alpha-diversity
時間枠:Baseline, week 6
|
Assessed via16S rRNA sequencing |
Baseline, week 6
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
HDL-C concentrations
時間枠:Baseline, week 6
|
Lipid profile |
Baseline, week 6
|
|
Total cholesterol concentrations
時間枠:Baseline, week 6
|
Lipid profile |
Baseline, week 6
|
|
Triglyceride concentrations
時間枠:Baseline, week 6
|
Lipid profile |
Baseline, week 6
|
|
Gut microbiome abundance
時間枠:Baseline, week 6
|
16S rRNA sequencing |
Baseline, week 6
|
|
LPS-binding protein concentration
時間枠:Baseline, week 6
|
Intestinal permeability marker |
Baseline, week 6
|
|
Glucose concentrations
時間枠:Baseline, week 6
|
Blood Glucose |
Baseline, week 6
|
|
Insulin concentrations
時間枠:Baseline, week 6
|
Insulin |
Baseline, week 6
|
|
Body mass
時間枠:Baseline, week 3, and week 6
|
Measured in kg |
Baseline, week 3, and week 6
|
|
Fat mass
時間枠:Baseline, week 3, and week 6
|
Fat mass |
Baseline, week 3, and week 6
|
|
Fat-free mass
時間枠:Baseline, week 3, and week 6
|
Fat-free mass |
Baseline, week 3, and week 6
|
|
Waist circumference
時間枠:Baseline, week 3, and week 6
|
Waist circumference |
Baseline, week 3, and week 6
|
|
Hip circumference
時間枠:Baseline, week 3, and week 6
|
Hip Circumference |
Baseline, week 3, and week 6
|
|
Thigh circumference
時間枠:Baseline, week 3, and week 6
|
Thigh Circumference |
Baseline, week 3, and week 6
|
|
24 hour appetite ratings
時間枠:Baseline, week 6
|
24-hour appetite ratings assessed on VAS |
Baseline, week 6
|
|
Physical activity scores
時間枠:Baseline, week 6
|
Activity assessment using Actigraphs |
Baseline, week 6
|
|
Total hours of sleep
時間枠:Baseline, week 6
|
Sleep diary |
Baseline, week 6
|
|
Palatability rating of foods
時間枠:Baseline, week 3, week 6
|
Hedonic general labelled magnitude scale (gLMS) |
Baseline, week 3, week 6
|
|
Acceptance rating of foods
時間枠:Baseline, week 3, week 6
|
9-point food action rating scale |
Baseline, week 3, week 6
|
|
Taste and flavor intensity ratings of foods
時間枠:Baseline
|
Sensory intensity scales |
Baseline
|
|
Gene expression levels
時間枠:Baseline, week 6
|
Transcriptomics analyses |
Baseline, week 6
|
|
Inflammatory marker concentrations
時間枠:Baseline, week 6
|
Inflammatory markers |
Baseline, week 6
|
|
Healthy eating index score
時間枠:Baseline, week 6
|
NCI diet history questionnaire |
Baseline, week 6
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Metabolite intensities
時間枠:Baseline, week 6
|
Untargeted and targeted metabolomics |
Baseline, week 6
|
|
Nutrient intakes
時間枠:Baseline, week 3, week 6
|
24 hours dietary recall |
Baseline, week 3, week 6
|
協力者と研究者
捜査官
- 主任研究者:Jaapna Dhillon, PhD、University of Missouri-Columbia
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- 2097458
- 2097458 (その他の識別子:University of Missouri)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Individual participant data that underlie the results reported here after deidentification (ie; text, tables, figures, and appendices)
IPD 共有時間枠
Immediately following publication. No end date.
IPD 共有アクセス基準
Data will be deposited in online repositories
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。